Gunderson Dettmer Stough Villeneuve Franklin & Hachigian acted as counsel to Tarsus Pharmaceuticals in the offering, Hogan Lovells acted as regulatory counsel while Knobbe Martens Olson...
Tarsus Pharmaceuticals’ $115.0 Million Common Stock Offering
Viridos’ $25 Million Series A Financing
Gunderson Dettmer represented Viridos on the deal. Viridos, the leading algae biofuel company, announced its $25 million Series A financing led by Breakthrough Energy Ventures (BEV) and...
BigHat’s $75 Million Series B Financing
Gunderson Dettmer represented client Section 32 on the deal while Wilson Sonsini advised BigHat Biosciences. Section 32, a venture capital fund that invests in frontiers of...